ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

SCIEX Launches the New Cornerstone of Software Ecosystem - SCIEX OS 3.0

Features include Zeno SWATH DIA, stMRM, an integrated central console and accessibility across 9 languages

At ASMS 2022, SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches SCIEX OS software v3.0, a software ecosystem built on accessibility, connectivity and integration. With this launch, SCIEX OS software powers mass spectrometers across the SCIEX portfolio and enables the SCIEX ecosystem to deliver better quality data, boosted workflow efficiencies and comprehensive auditing advancements.

In addition to enabling Zeno SWATH DIA, also launched today, SCIEX OS software v3.0 features stMRM, a data rich, scout triggered MRM workflow. stMRM couples improved efficiency with better-quality data across vast screening workflows. It utilizes the intelligent monitoring of marker compounds to trigger the acquisition of later eluting dependent transitions to identify dependent compounds. stMRM removes analytical dependencies of chromatographic retention times allowing for improved cycle and dwell across compound transitions.

“Scout triggered MRM is being used at our institution to monitor 300 characteristic peptides in an 8 minute run-time, to specifically identify the pathogens concerned with sepsis. This research could start to impact patients in as little as 3 years,” said Jérôme Lemoine from Claude Bernard Lyon 1 University.

SCIEX OS software v3.0 brings laboratory administration to a new level of efficiency and comprehension with the launch of the Central Administration Console. This new feature brings project management, user profiles, permissions and security into a simple and navigable interface.

In addition, this launch improves accessibility to SCIEX systems with new language packs. Customers will now be able to operate SCIEX OS software in 9 languages: Chinese (simplified), English, French, German, Italian, Japanese, Korean, Portuguese and Spanish.

“Globally, customers have told us they need to be connected to their data. They need it to be readily accessible. They need software, free of barriers and obstacles that will evolve as their challenges evolve, and interpret data in a way that unlocks biological meaning. Connecting people to their pursuits and the pursuits of others is the inspiration for creating this unified software ecosystem,” said Joe Fox, President at SCIEX.

To learn more about SCIEX OS software v3.0, see www.sciex.com/sciexos.

About SCIEX

SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all. We have been at the forefront of the field of mass spectrometry for 50 years. From the launch of the first ever commercially successful triple quadrupole in 1981, we have developed groundbreaking technologies and solutions that influence life-changing research and outcomes.

Today, as part of the Danaher Corporation (NYSE:DHR) family of global science and technology companies, we continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis. Our customers can quickly respond to environmental hazards, better understand biomarkers relevant to disease, improve patient care in the clinic, bring relevant drugs to market faster and keep food healthier and safer.

That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions that positively impact lives.

For more information, visit sciex.com.

Let’s connect: Twitter, LinkedIn, Facebook, and Instagram.

Advances in human wellness depend on the power of precise science.

The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to www.sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures.

Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries (see www.sciex.com/trademarks).

© 2022 DH Tech. Dev. Pte. Ltd. RUO-MKT-12-14840-A.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.